McKesson moves medicine. As a top pharmaceuticals distributor in North America, McKesson delivers prescription and generic drugs, as well as health and beauty care products, to more than 40,000 retail and institutional pharmacies throughout the US. The company is also a major medical supplies wholesaler, providing medical and surgical equipment to alternate health care sites, such as doctors' offices, surgery centers, and long-term care facilities. In addition to distribution services, McKesson offers software and technical services that help pharmacies, health care providers, and insurers manage supply chain, clinical, administrative, and financial operations.
Track this company’s financial condition.
View Company Report
Request Your Free Trial
| Income Statement | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|
| Revenue | $122455.0 | $122734.0 | $112084.0 | $108702.0 | $106632.0 |
| Gross Profit | $6984.0 | $6567.0 | $5970.0 | $5676.0 | $5378.0 |
| Operating Income | $2315.0 | $2149.0 | $1821.0 | $2008.0 | $1196.0 |
| Net Income | $1338.0 | $1403.0 | $1202.0 | $1263.0 | $823.0 |
| Diluted EPS | $5.59 | $5.59 | $4.57 | $4.62 | $2.95 |
| Cash Flow (mil) | 2013 | 2012 | 2011 |
|---|---|---|---|
| Cash at the beginning of the year | $3149.0 | $3612.0 | $3731.0 |
| Net Operating Cash | $2483.0 | $2950.0 | $2338.0 |
| Net Investing Cash | $-2209.0 | $-1502.0 | $-624.0 |
| Net Financing Cash | $-956.0 | $-1905.0 | $-1841.0 |
| Net Change in Cash | $-693.0 | $-463.0 | $-119.0 |
| Cash at end of the year | $2456.0 | $3149.0 | $3612.0 |
| Capital Expenditure | $-406.0 | $-403.0 | $-388.0 |
| Assets (mil) | 2013 | 2012 | 2011 |
|---|---|---|---|
| Current Assets | |||
| Cash | $2456.0 | $3149.0 | $3612.0 |
| Net Receivables | $9975.0 | $9977.0 | $9187.0 |
| Inventories | $10335.0 | $10073.0 | $9225.0 |
| Other Income Assets | $404.0 | $404.0 | $333.0 |
| Asset Summary | |||
| Total Current Assets | $23170.0 | $23603.0 | $22357.0 |
| Net Fixed Assets | $1321.0 | $1043.0 | $991.0 |
| Other Noncurrent Assets | $10295.0 | $8447.0 | $7538.0 |
| Total Assets | $34786.0 | $33093.0 | $30886.0 |
| Liabilities (mil) | 2013 | 2012 | 2011 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $16108.0 | $16114.0 | $ |
| Short Term Debt | $352.0 | $908.0 | $417.0 |
| Other Current Liabilities | $4897.0 | $4664.0 | $18309.0 |
| Liability Summary | |||
| Total Current Liabilities | $21357.0 | $21686.0 | $18726.0 |
| Long Term Debt | $4521.0 | $3072.0 | $3587.0 |
| Other Noncurrent Liabilities | $1838.0 | $1504.0 | $1353.0 |
| Total Liabilities | $27716.0 | $26262.0 | $23666.0 |
| Stakeholder's Equity (mil) | 2013 | 2012 | 2011 |
|---|---|---|---|
| Equity | |||
| Preferred Stock Equity | $0.0 | $0.0 | $0.0 |
| Common Stock Equity | $7070.0 | $6831.0 | $7220.0 |
| Equity Summary | |||
| Total Equity | $7070.0 | $6831.0 | $7220.0 |
| Shares Outstanding | 227.0 | 235.0 | 252.0 |